Zacks: Adamis-Pharmaceuticals-Corporation (ADMP) Given $7.50 Consensus Target-Price by Brokerages Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation. http://dailyquint.com/2017-01-20-zacks-adamis-pharmaceuticals-corporation-admp-given-7-50-consensus-target-price-by-brokerages/